A., Zambon, A., Barter, P., Fruchart, J., Eckel, R
Collagen peptides have more human data on knee osteoarthritis symptoms, but even there, results are mixed and effect sizes are often modest
This research compound incorporates an N-terminal tyrosine modification for structural stability and demonstrates targeted lipolytic activity by modulating beta-3 adrenergic receptors without elevating IGF-1 levels or inducing insulin resistance
Not for human or animal use, and not suitable for diagnostic or therapeutic applications
Visual Format: Side-effect and safety matrix Key Labels: Topical irritation, allergic reaction, formulation sensitivity, wound-care context, injectable route, limited safety data, peptide impurities, immunogenicity risk Suggested Layout: Create a three-column matrix: Topical products, Wound-care study context, and Injectable or compounded preparations. Under each column, list route-specific safety considerations using short, neutral labels